Reversed-Phase Analyses of Monoclonal Antibodies Using High Temperatures
The Application Notebook
This application note shows how to achieve robust chromatographic results for two commercially available mAbs: Adalimumab (Humira®) and Bevacizumab (Avastin®).
Monoclonal antibodies (mAbs) are immunological active proteins, which bind specifically to certain cells or proteins. This will stimulate the immune system to attack those targets.
mAbs are very important for the treatment of different kinds of cancer and autoimmune diseases. Nowadays, a broad variety of therapeutical antibodies are available on the market and several more are in research and development.
Due to their molecular weight of about 150 kDa, intact antibodies are usually analyzed by IEX, SEC, or HIC. In addition, reversedâphase methods are an easy tool as well.
However, a lack of sensitivity and resolution has been a hurdle in the past. With modern reversed phases addressing the requirements of these analytes, it is easy to find a suitable method.
Successful analysis in reversed-phase mode for mAbs is enhanced by employing a temperature stable (> 60 °C), widepore stationary phase.
This application note shows how to achieve robust chromatographic results for two commercially available mAbs: Adalimumab (Humira®) and Bevacizumab (Avastin®).
The increase in temperatures leads to higher sensitivity and a sharper peak of Adalimumab at temperatures >60 °C (Figure 1).
Bevacizumab shows robust results starting from 70 °C, whereas at lower temperatures no peak was detected (Figure 2).
With YMC-Triart Bio C4, elevated temperatures can easily be applied, due to stability up to 90 °C. In addition, the surface comprising 30 nm/300 Å is beneficial for resolution. In combination with a wide pH range of 1–10 YMC-Triart Bio C4 is a well-suited tool for any mAb (U)HPLC method.
YMC Europe GmbH
Tel.: +49 2064 4270
E-mail: info@ymc.de
Website: www.ymc.de
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
